Jazz Pharmaceuticals JAZZ releases its next round of earnings this Tuesday, August 03. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report.
Net Income, Earnings, And Earnings Per Share
Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS.
Earnings And Revenue
Wall Street analysts see Jazz Pharmaceuticals reporting earnings of $3.42 per share on revenue of $735.62 million. In the same quarter last year, Jazz Pharmaceuticals announced EPS of $3.71 on revenue of $562.44 million.
What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?
Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.
If the company were to report earnings in line when it publishes results Tuesday, quarterly profit would be down 7.82%. Sales would be up 30.79% on a year-over-year basis. Here is how the Jazz Pharmaceuticals's reported EPS has stacked up against analyst estimates in the past:
| Quarter | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|
| EPS Estimate | 3.74 | 4.2 | 4.08 | 3.11 |
| EPS Actual | 3.92 | 4 | 4.31 | 3.71 |
| Revenue Estimate | 611.49 M | 639.55 M | 577.58 M | 504.65 M |
| Revenue Actual | 607.58 M | 665.52 M | 600.89 M | 562.44 M |
Want Real-Time Earnings Calendar Updates?
Benzinga consistently updates its earnings calendars to stay up-to-date with the latest company earnings reports. Check out the full earnings calendar list updated in real-time by following this link.
Stock Performance
Shares of Jazz Pharmaceuticals were trading at $169.52 as of July 30. Over the last 52-week period, shares are up 53.96%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
Do not be surprised to see the stock move on comments made during its conference call. Jazz Pharmaceuticals is scheduled to hold the call at 16:30:00 ET and can be accessed here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
